Case Report of a Patient with Dual Positivity for Anti-GBM and MPO-ANCA Antibodies
Author Information
Author(s): Etter Christoph, Gaspert Ariana, Regenass Stephan, Wüthrich Rudolf P, Kistler Thomas, Kain Renate, Cohen Clemens D
Primary Institution: University Hospital Zurich
Hypothesis
Can anti-hLAMP2 antibodies indicate a clinical course similar to ANCA-associated vasculitis in double-positive patients?
Conclusion
Anti-hLAMP2 antibodies may indicate a relapsing disease course in patients with dual positivity for anti-GBM and MPO-ANCA antibodies.
Supporting Evidence
- The patient had dual positivity for anti-GBM and MPO-ANCA antibodies.
- Plasmapheresis and immunosuppressive therapy led to initial remission.
- The disease relapsed after two years despite treatment.
- Anti-hLAMP2 antibody levels correlated with clinical disease activity.
Takeaway
This study is about a woman who had a rare combination of two types of antibodies that made her illness harder to treat, but a new antibody test might help doctors understand her condition better.
Methodology
The patient's serum was tested for various antibodies, and renal biopsies were performed to assess kidney damage.
Limitations
The findings are based on a single case report, which limits generalizability.
Participant Demographics
A 52-year-old non-smoking woman.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website